About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Buprenorphine Maintenance Protocol - 1 | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 3NCT00000205

Buprenorphine Maintenance Protocol - 1

The purpose of this study is to compare the efficacy of buprenorphine versus methadone.

Lead sponsor: University of California, Los Angeles•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

University of California, Los Angeles

Collaborators

National Institute on Drug Abuse (NIDA)

Age

21 - 50 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•M/F ages 21-50. Opiate dependence according to DSM-IV criteria. Self-reported use within the last 30 days. Agreeable to conditions of study and signed informed consent.

Exclusion Criteria

•Psychiatric disorder that requires medication therapy. History of seizures. Pregnant and /or nursing women. Dependence on ETOH or benzodiazepines or other sedative/hynotics. Acute hepatitis. Other medical conditions that deem participation to be unsafe

Related studies

Outcome Inference in the Sensory Preconditioning Task in Opioid-Use Disorder

NCT03745339 · Opioid-Related Disorders, Drug Addiction

RECRUITINGPhase 2

Neurocognitive Mechanisms Underlying Smartphone-Assisted Prevention of Relapse in Opioid Use Disorder

NCT05336188 · Opioid-Related Disorders, Mobile Applications, and more

Enrolling By InvitationNA

Alliances to Disseminate Addiction Prevention and Treatment (ADAPT)

NCT04499079 · Substance-Related Disorders, Recidivism, and more

Active Not RecruitingEARLY Phase 1

Tau PET Imaging in Opioid Use Disorder

NCT05651516 · Opioid-Related Disorders

Active Not RecruitingNA

Feasibility of Deep Brain Stimulation as a Novel Treatment for Refractory Opioid Use Disorder

NCT03950492 · Opioid-Related Disorders

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 11, 2016Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE3

Enrollment—

Start dateOct 1990

Last updatedJul 11, 2016

Condition

Opioid-Related Disorders

Locations shown

Friends Research Institute

Los Angeles, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 11, 2016Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions